This week 2020health is producing its third report on obesity: Tackling obesity – What the UK can learn from other countries. The prevalence of overweight and obesity among adults and children has never been higher in the UK, so what … Continue reading
Guest Blog by Robin Millar, Acting Chief Executive, 2020health Obesity is a complex issue – like health itself, it affects how we live our daily lives, the environment in which we live and work and how we feel about ourselves. In … Continue reading
Guest Blog by BDA Chairman, Dr Fiona McCullough Dietitians Week (8-12 June 2015), is led by the British Dietetic Association (BDA) and provides a fantastic opportunity to promote the dietetic profession nationally and even globally. The BDA, founded in 1936, … Continue reading
Today’s report on weight-loss surgery is another warning to government on the social, economic and personal costs of obesity. It shows that about 5% of those having surgery are aged 25 years or under and 40% of them were ‘super-obese’, … Continue reading
The UK National Institute for Health and Care Excellence (“NICE”) is currently holding a public consultation over its proposals for evaluating drugs. Drugs that are approved by NICE automatically become available for doctors to prescribe under the NHS throughout England … Continue reading
Posted in Business, CCGs, Commissioning, Department of Health, Drugs, Elderly, equality, Genetics, GPs, Health and Wellbeing, Health Bill, Health reform, Inequality, Innovation, Jeremy Hunt, NHS, NHS reforms, Patients, Pharma, Policy, Public Health, Research, Technology, Uncategorized, Wellbeing
Tagged 2020health, Clinical Commissioning Group, Commissioning, Department of Health, dose, elderly, General practitioner, government, GP, GPs, health, Health Bill, innovation, Jeremy Hunt, medicine, Medicines and Healthcare products Regulatory Agency, MHRA, National Health Service, National Institute for Health and Care Excellence, NHS, NICE, Old age, patient, Patients, pharmaceutical, PPRS, pricing, Proportionate QALY, Public Health, QALY, R&D, Research, value-based, value-based pricing
Great to see UK Universities developing innovative technologies to solve developing world public health problems.